Sherwin-Williams Q3 sales beat estimates on higher pricing
SHW•Sherwin-Williams’ third-quarter sales rose 7.9% to $6.86 billion, above the $6.78 billion consensus, while adjusted EPS of $3.63 missed estimates of $3.68. The company expects mid-single-digit sales growth in Q4 and narrowed its 2026 adjusted diluted EPS guidance to $11.85-$12.15.
1. Quarterly results
Third-quarter sales increased 7.9% to $6.86 billion, beating analyst expectations of $6.78 billion. Adjusted EPS rose 1.1% to $3.63, below the $3.68 consensus. Higher selling prices contributed to sales growth across all segments, while gross margin was pressured by higher raw material and supply chain costs, as well as mix effects including the Suvinil acquisition.
2. Company outlook
Sherwin-Williams expects fourth-quarter net sales to rise at a mid-single-digit rate from a year earlier. It expects 2026 full-year net sales to increase at a mid- to high-single-digit rate and narrowed its adjusted diluted EPS guidance to $11.85-$12.15.
